Characterization and management of hypercalcemia following transplantation for osteopetrosis
Open Access
- 5 October 2009
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 45 (5) , 939-944
Abstract
Autosomal recessive osteopetrosis (OP) is characterized by insufficient osteoclast activity resulting in defective bone resorption and marked increase in skeletal mass and density. OP has been successfully treated with hematopoietic cell transplantation (HCT), secondary to engraftment of donor-derived functioning osteoclasts resulting in remodeling of bone and establishment of normal hematopoiesis. Although hypercalcemia is a common presenting feature of OP, it may be observed following HCT due to engraftment of osteoclasts differentiated from the hematopoietic precursors. To characterize hypercalcemia after HCT—who is at risk, onset, duration and response to treatment—we evaluated 15 patients with OP treated at the University of Minnesota from 2000 to 2009. Hypercalcemia, defined as any single calcium >11.0 mg/100 ml after the first transplant, was found in 40% of patients. Median onset of hypercalcemia was 23 days and the duration was 2–24 days. Hypercalcemia was more common in patients older than 2 years of age at the time of HCT. Treatment with hydration, furosemide and s.c. calcitonin resolved hypercalcemia and resulted in no severe adverse events. In conclusion, hypercalcemia is common in patients with OP within the first 4 weeks after HCT, and more likely in older patients. Isotonic saline, furosemide and s.c. calcitonin were well-tolerated and effective treatments in our study population.Keywords
This publication has 23 references indexed in Scilit:
- Airway Evaluation and Management in 7 Children With Malignant Infantile Osteopetrosis Before Hematopoietic Stem Cell TransplantationJournal of Pediatric Hematology/Oncology, 2008
- Calcitonin ??? A Drug of the Past or for the Future?BioDrugs, 2008
- Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in childrenPediatric Nephrology, 2007
- Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantationBone Marrow Transplantation, 2000
- Bone marrow transplantation for autosomal recessive osteopetrosis A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation GroupThe Journal of Pediatrics, 1994
- Recombinant human interferon gamma therapy for osteopetrosisThe Journal of Pediatrics, 1992
- Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation.Archives of Disease in Childhood, 1991
- Cells That Resorb BoneNew England Journal of Medicine, 1984
- Treatment of Congenital Osteopetrosis with High-Dose CalcitriolNew England Journal of Medicine, 1984
- Successful Bone-Marrow Transplantation for Infantile Malignant OsteopetrosisNew England Journal of Medicine, 1980